Helix Sequencing vs SelfDecode

SelfDecode and Helix Sequencing both use AI and accept uploads from 23andMe and AncestryDNA. But they serve different purposes with different philosophies. SelfDecode positions itself as an “AI-powered personalized health platform” that combines genetics with blood work to generate supplement and lifestyle recommendations. Helix Sequencing runs a clinical-grade analysis pipeline — 3,550+ peer-reviewed polygenic risk scores, 34-gene CPIC pharmacogenomics, and ClinVar variant scanning — then lets you connect the results to any AI assistant.

The most important difference is not the analysis itself but the business model: SelfDecode locks your reports behind a recurring subscription, and Helix gives you data you own forever with a one-time purchase.

Quick Comparison

What SelfDecode Offers

SelfDecode was founded by Joe Cohen, creator of the SelfHacked health blog. The platform offers 200+ health and trait reports covering cardiovascular health, mental health, autoimmune conditions, hormones, metabolism, cognitive function, and more. They claim to analyze up to 83 million genetic variants through imputation from a standard genotyping chip.

Their differentiating featuresinclude an AI chatbot (“Joe”) that answers health questions using your genetic and lab data, a lab analyzer that combines blood work with genetics, and personalized supplement recommendations. They sell their own DNA kit but also accept uploads from 23andMe and AncestryDNA.

SelfDecode operates on a subscription model at $97-$199/year. This is the most contentious aspect of their service: if you cancel, you lose access to your health reports. This is the #1 complaint in user reviews.

The Subscription Problem

SelfDecode’s subscription model means you are renting access to your own health data. Stop paying, and your reports, recommendations, and AI access disappear. Your DNA doesn’t change, but your ability to see what it says depends on a recurring payment.

Helix Sequencing takes the opposite approach. You pay $50 once and receive your complete analysis: interactive HTML report, doctor-ready PDF, structured JSON, and full export capabilities. These files are yours forever. No subscription. No paywall. No re-payment to see your own results.

Over two years, SelfDecode costs $194-$398 in subscription fees. Helix costs $50 once. The Helix report is more comprehensive (3,550+ PRS vs 200+ reports) and you own it permanently.

Scientific Rigor: Peer-Reviewed vs Proprietary

PRS Methodology

This is a critical distinction. SelfDecode uses proprietary PRS methodology that is not published or peer-reviewed. Their risk scoring models are developed internally, and the methodology is not available for independent scrutiny. You are trusting their internal team to build accurate risk predictions without external validation.

Helix Sequencing runs all 3,550+ models from the PGS Catalog— maintained by EMBL-EBI and the University of Cambridge. Every model was developed by research institutions, published in peer-reviewed journals, and deposited in a curated repository. This is the same scoring infrastructure being adopted by research hospitals for clinical use.

The “83 Million Variants” Claim

SelfDecode markets that they analyze “up to 83 million genetic variants.” This is achieved through statistical imputationfrom a standard genotyping chip (~600-700K directly measured SNPs). Imputation is a legitimate technique — Helix uses it too (Beagle 5.5, expanding to 28M+ variants).

The difference is transparency. Helix clearly communicates that imputation is statistical inference, not direct measurement, and discloses accuracy limitations. SelfDecode’s “83 million” headline can mislead consumers into thinking all variants were directly measured. For rare variants (MAF <1%), imputation accuracy drops significantly, and those imputed positions should not be treated with the same confidence as directly genotyped ones.

The Supplement Conflict of Interest

SelfDecode sells its own supplement line and actively promotes these products within health reports. When a platform recommends supplements and also profits from selling them, there is an inherent conflict of interest. Users have noted that recommendations sometimes feel like they are designed to drive supplement purchases rather than provide unbiased health guidance.

Helix Sequencing does not sell supplementsand has no financial incentive tied to its health recommendations. The longevity protocol is generated based on your risk scores and published research. If it recommends magnesium glycinate, it’s because your genetic data and the literature support it, not because there’s a product to sell.

When SelfDecode Makes Sense

When to Choose Helix Sequencing

Frequently Asked Questions

Key Takeaways